Download Citation
Article Source:
The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo
Lucas DM,
Alinari L,
West DA,
Davis ME,
Edwards RB,
et al.
(2010)
The Novel Deacetylase Inhibitor AR-42 Demonstrates Pre-Clinical Activity in B-Cell Malignancies In Vitro and In Vivo.
PLOS ONE 5(6): e10941.
https://doi.org/10.1371/journal.pone.0010941